Please check your internet connection and try again.
## Tus%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd
### Overview
Tus%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd is a combination product that typically contains a cough suppressant (antitussive) and may include other ingredients like expectorants or antihistamines depending on the specific formulation. The "-qd" likely indicates a specific dosing frequency, such as "once daily" or "four times daily" based on context, but the exact meaning requires clarification of the product name.
### Primary Indications
Symptomatic relief of cough. Specific indications will vary based on the full composition of the product.
### Adult Dosing
Dosing is formulation-dependent. If it contains dextromethorphan, typical doses range from 10 mg to 20 mg every 4 hours, or 30 mg every 6-8 hours. Maximum daily doses for dextromethorphan are generally 120 mg. If other active ingredients are present, their specific dosing requirements must be followed.
### Pediatric Dosing
Dosing is formulation-dependent and age-specific. For dextromethorphan, pediatric dosing varies significantly by age:
* **Ages 6 to <12 years:** 7.5 mg to 15 mg every 4 hours, or 30 mg every 6-8 hours. Maximum daily dose typically 60 mg.
* **Ages 2 to <6 years:** 7.5 mg every 4 hours. Maximum daily dose typically 30 mg.
* **Under 2 years:** Use is generally not recommended due to increased risk of adverse effects. Consult a pediatrician.
**Note:** Combination products may have different pediatric dosing guidelines or may not be recommended for pediatric use.
### Dose Adjustments
* **Renal Impairment:** No specific dose adjustment is typically required for dextromethorphan in mild to moderate renal impairment. Use with caution in severe renal impairment.
* **Hepatic Impairment:** Use with caution in hepatic impairment as metabolism may be reduced.
### Contraindications
* Hypersensitivity to any component of the formulation.
* Use within 14 days of MAOI therapy.
* Cough associated with excessive secretions.
* Asthma or chronic bronchitis (for certain formulations).
### Adverse Effects
Common: Dizziness, drowsiness, nausea, vomiting, constipation.
Less common: Confusion, hallucinations, respiratory depression (especially with overuse or in combination with other CNS depressants).
### Key Drug Interactions
* **MAO Inhibitors:** Risk of serotonin syndrome or hypertensive crisis.
* **SSRIs, SNRIs, TCAs, Triptans:** Increased risk of serotonin syndrome.
* **CNS Depressants (e.g., alcohol, benzodiazepines, opioids):** Increased sedation and respiratory depression.
* **CYP2D6 Inhibitors (e.g., fluoxetine, paroxetine, quinidine):** May increase dextromethorphan levels, increasing risk of toxicity.
### Monitoring
* Assess cough effectiveness and presence of adverse effects.
* Monitor for signs of CNS depression or serotonin syndrome if concomitant medications increase risk.
### Clinical Pearls
* The "-qd" suffix is critical for understanding the dosing frequency; confirm its meaning.
* Dextromethorphan is a CYP2D6 substrate; genetic variability can affect metabolism and response.
* Advise patients to avoid alcohol and other CNS depressants while taking this medication.
* If cough persists for more than 7 days, advise patient to seek medical attention.
* Consider the presence of other active ingredients in combination products and their associated safety profiles.
***
**Disclaimer:** This information is intended for clinical decision support and does not replace a thorough review of the most current prescribing information and clinical guidelines. Always verify current drug information before making therapeutic decisions.
